Gilead Sciences reported $7.42B in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acorda Therapeutics ACOR:US $ 31.46M 0.33M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
ALKERMES ALKS:US $ 294.14M 9.58M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biogen BIIB:US $ 2778.9M 3.9M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Bristol Myers Squibb BMY:US $ 11624M 79M
Coherus Biosciences CHRS:US $ 82.5M 5.14M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
Glaxosmithkline GSK:US $ 9077M 985M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
Johnson & Johnson JNJ:US $ 23338M 26M
Merk MRK:US $ 13154M 1752M
Moderna Inc MRNA:US 4.97B 615M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Novartis NOVN:VX SF 13367M 73M
Pfizer PFE:US $ 24094M 5117M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Puma Biotechnology PBYI:US $ 46.24M 7.14M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
United Therapeutics UTHR:US $ 444.7M 1.8M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
YTE INCY:US $ 812.99M 107.28M